Gary Bravo-Alvarez

Dr. Josep Trueta University Hospital
Girona, CT 17001, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

Ozanimod Reduces Serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP) and Modulates Innate and Adaptive Immunity in Patients with Low-to-Moderate Activity Relapsing-Remitting Multiple Sclerosis.

Journal: International journal of molecular sciences
Published: April 15, 2026

Correction: Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors.

Correction: Differences in metacognition between multiple sclerosis phenotypes: cognitive impairment and fatigue are key factors.

Journal: Frontiers in psychology
Published: March 24, 2026

Anti-Ma2 encephalitis: when the examination localises beyond MRI.

Anti-Ma2 encephalitis: when the examination localises beyond MRI.

Journal: Practical neurology
Published: March 09, 2026

A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.

A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline.

Journal: Frontiers in immunology
Published: February 02, 2026

Large language models as clinical decision-support tools in multiple sclerosis and neuromyelitis optica spectrum disorders: A comparative study of ChatGPT-4o and neurologists.

Large language models as clinical decision-support tools in multiple sclerosis and neuromyelitis optica spectrum disorders: A comparative study of ChatGPT-4o and neurologists.

Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: January 27, 2026

Brueghel syndrome: A missing entity. Case report.

Brueghel syndrome: A missing entity. Case report.

Journal: Neurologia
Published: January 24, 2026

Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study.

Rituximab and IVIG added to plasma exchange improves the outcome of severe CNS demyelinating attacks: a retrospective study.

Journal: Therapeutic advances in neurological disorders
Published: January 09, 2026

Cardiac involvement in anti-GABA-B receptor encephalitis: a case report.

Cardiac involvement in anti-GABA-B receptor encephalitis: a case report.

Journal: BMJ neurology open
Published: September 15, 2025

From adaptive to maladaptive hippocampal resting-state functional connectivity over the course of multiple sclerosis to understand memory impairment.

From adaptive to maladaptive hippocampal resting-state functional connectivity over the course of multiple sclerosis to understand memory impairment.

Journal: NeuroImage. Clinical
Published: August 08, 2025

Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome.

Reduced CD40 expression in B cell subsets of individuals with radiologically isolated syndrome.

Journal: Frontiers in immunology
Published: August 05, 2025

Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.

Cerebrospinal 14-3-3 Protein Levels as a Neuroaxonal Biomarker in Aquaporin-4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder.

Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 30, 2025

Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis.

Combining CSF and Serum Biomarkers to Differentiate Mechanisms of Disability Worsening in Multiple Sclerosis.

Journal: International journal of molecular sciences
Published: June 24, 2025
Showing 1-12 of 32

Last Updated: 09/26/2026